Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
Actual shortage: | 256 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2412 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CLONIDINE | 0.2MG | TABLET | Resolved | 2023-02-16 | 2023-10-04 | 184946 |
TEVA-TADALAFIL | 10MG | TABLET | Resolved | 2023-02-16 | 2023-04-28 | 184943 |
TEVA-TEMOZOLOMIDE | 20MG | CAPSULE | Resolved | 2023-02-16 | 2023-04-28 | 184940 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2023-02-16 | 2023-06-09 | 184937 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-02-16 | 2023-06-09 | 184934 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-02-16 | 2023-08-04 | 184931 |
TEVA-FLUTICASONE | 50MCG | METERED-DOSE PUMP | Resolved | 2023-02-16 | 2023-04-28 | 184928 |
TEVA-DILTIAZEM XC | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-02-16 | 2023-04-28 | 184925 |
TEVA-DILTIAZEM XC | 240MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-02-16 | 2023-04-28 | 184922 |
TEVA-DILTIAZEM XC | 180MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-02-16 | 2023-04-28 | 184919 |
TEVA-NITROFURANTOIN | 100MG | CAPSULE | Resolved | 2023-02-16 | 2023-04-28 | 184916 |
LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Resolved | 2023-02-10 | 2023-03-23 | 184317 |
TEVA-DEXTROAMPHETAMINE SR | 15MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2023-02-09 | 2023-06-09 | 184225 |
TEVA-AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-02-09 | 2023-11-30 | 184222 |
TEVA-AMPHETAMINE XR | 5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-02-09 | 2023-07-28 | 184219 |
TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Actual shortage | 2023-02-09 | 2024-04-25 | 184216 |
TEVA-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-02-09 | 2023-04-28 | 184213 |
TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2023-02-09 | 2023-04-28 | 184210 |
TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2023-02-09 | 2023-02-16 | 184207 |
ACT AMLODIPINE | 5MG | TABLET | Resolved | 2023-02-09 | 2023-04-28 | 184204 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |
EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |